By Jack Lynch, president and CEO, MLH
Main Line Health is conducting a very brief (4 question) survey to learn about your perception of power gradients within our System. As you know, the Power Gradient Reporting and Resolution Policy was implemented in September 2018 to assure that staff concerns are addressed in a timely and equitable manner.
Your feedback is critical to helping us evaluate our progress to-date. Please review the links below and follow the appropriate one based on your role to complete the survey by June 30. The survey should take no more than a few minutes to complete. If you have any questions, please contact Anne Marie Browne, director, Patient Safety & Quality at firstname.lastname@example.org or 484.337.2007.
MLH Pulse Hospital Survey on Patient Safety Culture for Staff who Provide Patient Care or Clinical Services
MLH Pulse Hospital Survey on Patient Safety Culture for Staff who Do Not Provide Patient Care or Clinical Services
MLH Pulse Medical Office Survey on Patient Safety Culture
By Karen Fritz, assistant marketing manager
On Tuesday, June 18, phase II of construction in the parking lot at the Main Line Health Center in Newtown Square will begin. The canopy entrance will reopen, but Cancer Center patient parking as well as traffic flow and parking for visitors and staff are still affected. Please refer to the PDF map to identify new traffic flow and parking areas for staff, patients and visitors. There will also be directional signage onsite.
As always, our first priority is ensuring a superior experience for our patients. As such, please be mindful that patient and visitor parking are temporarily moved to the employee parking area in order to allow them to enter and exit our building as easily as possibly. All staff is asked to offer assistance to patients and visitors who may need help navigating. We apologize for this temporary inconvenience and thank you for your patience and cooperation during this time.
Researchers and clinicians: To see upcoming educational seminars offered by the Lankenau Institute for Medical Research, click here.
The Business of Health Care Depends on Exploiting Doctors and Nurses
The New York Times: One resource seems infinite and free: the professionalism of caregivers.
Additional news media reports on MLH physicians and the health care industry, excerpted from MLH’s daily Morning News Report:
Regional Health News…
How Penn Medicine is tackling sepsis readmissions
Becker’s Hospital Review: Philadelphia-based Penn Medicine is working to reduce sepsis readmissions and improve life after sepsis for survivors with a new post-discharge care pathway.
Healthcare Business News…
Study pours cold water on idea that teaching hospitals are more costly for Medicare patients
Fierce Healthcare: Overall costs of care were similar or lower at teaching hospitals versus non-teaching hospitals for Medicare beneficiaries receiving common medical and surgical procedures, according to a new study funded by the Association of American Medical Colleges and published in JAMA Network Open.
Quality and Safety News…
Patients give more ‘5-star’ ratings to hospitals with fewer services
Reuters: Compared to smaller facilities, hospitals that provide complex care for critical illness or serious injury may find it harder to make patients happy, a U.S. study suggests.
Patient Care News…
Healthcare financial burden heavier for women, analysis finds
Becker’s Hospital Review: U.S. women face barriers to healthcare that men don’t, including higher costs, according to a new infographic released June 11.
Main Line Health employees who are trying to quit smoking are invited to attend the next SmokeFREE, a free six-session smoking cessation program. Participants may be eligible to receive free nicotine replacement therapy (patch, gum or lozenge) or Chantix at the copay price. Here are dates and locations of the SmokeFREE classes in the coming months.
“Data Mining in the Post-Genomic Era,” is the topic of the next seminar hosted by the Lankenau Institute for Medical Research. The seminar will take place on Thursday, June 20 at 2:00 pm in the McLean Conference Room, Lankenau Medical Center. All clinicians and researchers are welcome. Sudhir Nayak, PhD, professor in the School of Biology at The College of New Jersey, will discuss techniques and technologies he is using in his lab to better characterize genes.
Posted in Clinician News
Creating Connections, Conversations to Advance a Healthy Community for All, will be held on Friday October 18, 2019, 8am – 3pm at Lankenau Medical Center, Annenberg Conference Center. The program is a day of collaborative talks and roundtable discussions to assess the health of our community and highlight actions for change. Contact Megan Jones at Jonesme@mlhs.org or at 484.476.4625 for additional information.
This week’s STEEEP Huddle, contributed by Dane Menkin, CRNP, Divisional Director of LGBTQ Services, MLHC, highlights Pride Month which celebrates the impact that LGBTQ people have had in the world. As part of our diversity, respect and inclusion work, MLH has created LGBTQ Inclusive Care, aimed at helping to eliminate disparities in care among the LGBTQ community, working to ensure that their health needs are met and they receive compassionate, competent care. Learn more about MLH LGBTQ Inclusive Care on our website: https://www.mainlinehealth.org/specialties/lgbtq-inclusive-care
By Donna Loyle, communications specialist, LIMR
Main Line Health researchers seek patients diagnosed with recurrent, persistent or metastatic endometrial cancer for a randomized phase II clinical trial comparing the experimental drug cediranib, the FDA-approved therapy olaparib, and the combination of the two drugs.
Participants are randomized into three treatment groups:
- Arm 1: cediranib maleate, which is a drug that may help keep cancer cells from growing by affecting their blood supply
- Arm 2: Lynparza® (olaparib), a targeted therapy currently approved for patients diagnosed with recurrent ovarian or breast cancer
- Arm 3: both of those drugs
- Must have evaluable disease as defined by RECIST 1.1
- Tumors within a previously irradiated field will be designated as “non-target” lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy
- Must have had one prior chemotherapy for management of endometrial carcinoma, but must not have received any non-cytotoxic chemotherapy for management of recurrent or persistent disease; prior hormonal therapy is allowed
- Patients must have adequately controlled blood pressure and be willing and able to record their daily blood pressure readings
Study #NRG GY012 is approved for Lankenau Medical Center and Paoli Hospital. The principal investigators are Albert DeNittis, MD, and Paul Gilman, MD. For more, email email@example.com or visit https://www.mainlinehealth.org/research/clinical-trials/nrg-gy012
Posted in Clinician News
Gordon Chang, MD, has been named Main Line Health chief of neonatology. Dr. Chang has served as the interim chief of Neonatology at MLH since September 2018 and been a member of the MLH Neonatology physician group since 1997.
An accomplished clinician and researcher, Dr. Chang’s outstanding leadership abilities will guide MLH Neonatology to an even higher level of excellence. In his interim chief role, Dr. Chang headed several key initiatives including the incorporation of the Riddle Neonatal Intensive Care Unit into the Nemours Neonatology Group, expansion of the division and the Bryn Mawr Hospital NICU move to the new pavilion. Dr. Chang has also been highly involved in our quality and safety efforts and research initiatives at MLH, recently serving as a member of the Bryn Mawr Hospital Institutional Review Board.
Moving forward, Dr. Chang will continue to ensure that Main Line Health offers comprehensive services to our patients and delivers optimal care to the hundreds of critically ill newborns and infants we care for across the System each year.